Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Acumen Pharmaceuticals, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19
Revenues0.00.01.48.6
            Revenue growth -100.0%-83.3% 
Cost of goods sold0.00.00.015.5
Gross profit0.00.01.4-6.9
            Gross margin  100.0%-80.2%
Research and development32.412.38.0 
General and administrative12.97.31.40.9
EBIT-45.261.6-8.5-7.8
            EBIT margin  -591.8%-91.0%
Pre-tax income-42.9-100.6-7.3-7.9
Income taxes0.00.00.00.0
            Tax rate0.0%0.0%0.0%0.0%
Net income-42.9-100.6-7.30.0
            Net margin  -510.1%-0.1%
 
Diluted EPS($1.06)($5.02)($17.48)($17.84)
Shares outstanding (diluted)40.620.10.40.0
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy